Pfizer's Kevin Berry will have a speaker for the newest, most popular anticoagulant, Eliquis, for treatment of DVT and PE. Among some of the perks are - No need for weekly INRs and No continuous dosages adjustments for renal impaired patients. Come find out more about this new drug!
